Long-term metabolic risk for the metabolically healthy overweight/obese phenotype

AE Espinosa De Ycaza, D Donegan… - International journal of …, 2018 - nature.com
AE Espinosa De Ycaza, D Donegan, MD Jensen
International journal of obesity, 2018nature.com
Results: Of the 18 070 individuals with complete data at baseline, 1805 (10%) were MHO
(mean age 38±11 years) and 3047 were MHNW (mean age 35±11 years). After a median
follow-up of 15 years, interquartile range 10–17, 80% of MHO vs 68% of MHNW developed
at least one cardiometabolic risk factor (P< 0.001). In multivariate analysis, MHO individuals
who gained⩾ 10% of their body weight were more likely to have developed metabolic
complications compared to MHO individuals that did not gain weight (P= 0.001 for 10–15 …
Results:
Of the 18 070 individuals with complete data at baseline, 1805 (10%) were MHO (mean age 38±11 years) and 3047 were MHNW (mean age 35±11 years). After a median follow-up of 15 years, interquartile range 10–17, 80% of MHO vs 68% of MHNW developed at least one cardiometabolic risk factor (P< 0.001). In multivariate analysis, MHO individuals who gained⩾ 10% of their body weight were more likely to have developed metabolic complications compared to MHO individuals that did not gain weight (P= 0.001 for 10–15%, P< 0.001 for> 15% weight gain). The risk for the secondary composite end point was similar between MHO and MHNW, number of events 218/1805 vs 217/3048 for MHO and MHNW, respectively,(hazard ratio: 1.16, 95% confidence interval: 0.96–1.40).
Conclusions:
MHO are more likely to develop metabolic complications than MHNW, especially if they gain weight.
nature.com